Calibrate MAX System; Calibrate NanoTec MAX System; Calibrate CCX Interbody System; Calibrate NanoTec CCX Interbody System
Alphatec Spine, Inc. · Decision date Oct 21, 2026
What did the FDA decide?
On October 21, 2026, the FDA recorded a substantially equivalent (SESE) decision for K262646, a traditional 510(k) submitted by Alphatec Spine, Inc. of Carlsbad, California, and received July 30, 2026. The submission covers the Calibrate MAX System, Calibrate NanoTec MAX System, Calibrate CCX Interbody System and Calibrate NanoTec CCX Interbody System, classified under 21 CFR 888.3080 as an intervertebral body fusion device with bone graft, lumbar, Class II, product codes MAX and MQP. SESE denotes clearance, not premarket approval.
The summary describes expandable lumbar interbody fusion implants inserted via posterior or transforaminal approaches, made from titanium alloy, PEEK and cobalt chrome, with anti-migration teeth and grit-blasted endplate surfaces; the NanoTec variants add a 20–40 nanometer hydroxyapatite surface treatment. The primary predicate listed is K243461 (Calibrate Interbody Systems, cleared March 4, 2025), with additional predicates including K173025, K232173, K080699, K241375, K242147 and K033109. The source does not include the FDA's decision rationale or any clinical performance data.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Orthopedic
- Decision date
- Oct 21, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K262646
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- Alphatec Spine, Inc.
- Product code
- MAX
- Decision code
- SESE
- Decision date
- Oct 21, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Intervertebral Fusion Device With Bone Graft, Lumbar.
- Applicant
- Alphatec Spine, Inc.
- Product code
- MAX
- FDA device class
- 2
FDA decision timeline
K262646 received
Application receipt date recorded by FDA.
K262646 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
Other records with product code MAX
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Solco Biomedical Company India Private Limited | 510(k) clearance | Nov 6, 2026 | FDA | |
Symmetrix PX Spinal SystemK262572 | MEDTRONIC SOFAMOR DANEK USA, INC. | 510(k) clearance | Oct 29, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Alphatec Spine, Inc.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Carlsbad, CA
Sources and methodology
- Original FDA record: K262646
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records
